Clinical Characteristics | Number (%) | |
---|---|---|
Age (y) | Median (range) | 50 (46–72) |
Sex | Male | 9 (100.0) |
Female | 0 (0) | |
Hepatitis virus | HBV infection | 9 (100.0) |
HCV infection | 0 (0) | |
Tumour number | Median (range) | 1 (1–2) |
Tumour size (cm) | Median (range) | 5.0 (1.3–13.2) |
Tumour thrombosis | PVTT | 8 (88.9) |
IVCTT | 0 (0) | |
Previous therapy | Surgery | 1 (11.1) |
TACE | 7 (77.8) | |
RFA | 2 (22.2) | |
Systemic therapy | 0 (0) |